We present the case of a man who underwent successful heart transplantation with an allograft that was obtained from a donor who had already received heart transplantation.

Heart transplantation is the standard of care treatment for end-stage heart failure. Therapeutic advances including enhanced immunosuppression and aggressive infectious prophylaxis have led to increased life-expectancy following transplantation; however, cardiac allograft vasculopathy (CAV) remains a leading cause morbidity mortality. Although coronary angiography current guideline-recommended ...

BackgroundHeart transplantation is limited by the supply of donor organs. Previous studies have associated female to male recipient with decreased posttransplant survival. We wanted evaluate whether this risk can be mitigated using higher than body mass index (BMI).MethodsWe performed a retrospective analysis Organ Procurement and Transplantation Network/United Network Sharing registry encompas...

Background Stem cell transplantation has become as a novel treatment  for end-stage kidney, lung, heart , liver diseases and several hematologic disorders. Improved survival of transplant recipients has raised awareness of post-transplant complications. One of these complications is transplant-related osteoporosis. Methods  In this manuscript we review prevention methods for transplant-relat...

BACKGROUND In children with dilated cardiomyopathy who are on the waiting list for heart transplantation, we evaluate the seriousness of their hemodynamic conditions. Some develop cardiogenic shock, and the mortality rate is high. Even with inotropic and respiratory support, heart transplantation is considered an extremely grave circumstance. OBJECTIVE The objective of this study is to report...

OBJECTIVES This study sought to assess the incidence of transplant coronary artery disease (CAD) in Chinese heart recipients. BACKGROUND The prevalence of transplant CAD detected by angiography at 1, 2 and 4 years after heart transplantation was 11%, 22% and 45%, respectively. The incidence of transplant CAD in Chinese heart recipients has not been reported. METHODS For those recipients sur...

See Article page XXX. Presenter: Iris Feng Dr Francis Pagani (Ann Arbor, Mich). Thank you. An excellent presentation, and congratulations to you your team. It's a really important topic, obviously, because of the change in allocation system increase that we're seeing heart kidney transplantation. So observations are timely relevant. A couple questions, I think you've already addressed one them ...

We have read with great interest the recent article by Sammani et al. and the accompanying editorial by Y. Pinto in the Netherlands Heart Journal [1, 2]. Evidently, the current level of care for heart transplantation recipients in the Netherlands is high, as presented by the authors. Reasons for improved survival rates are the introduction of better immunosuppressive therapies and the improveme...

Systemic amyloidosis related to mutation of TTR gene can be complicated with Familial Amyloid Cardiomyopathy (TTR-FAC), a severe and life threatening form of heart failure with preserved ejection fraction, with a poor prognosis. To date there is no proven effective specific treatment against TTR-FAC, and the usual treatments of chronic heart failure are either ineffective or contra indicated, e...